Afshin Salsali MD

Diabetes, Lipid Metabolism

Physician

125 Paterson StSte 5200New Brunswick, NJ 08901
Phone+1 732-235-7219

Dr. Salsali is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Salsali's full profile Already have an account?

Education & Training

University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 1998 - 2001
Tehran University of Medical Sciences School of MedicineClass of 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

ND State Medical License Current
NJ State Medical License 2008 - 2027
VT State Medical License 2001 - 2012

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2013, 2016-2017
CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2013, 2016-2017
Fellow (FACE) American Association of Clinical Endocrinology

Publications & Presentations

PubMed

10 citations
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbAlevels (STEP-HFpEF DM): a prespecified analysis of...
Melanie J Davies, Peter van der Meer, Subodh Verma, Shachi Patel, Khaja M Chinnakondepalli
The Lancet. Diabetes & Endocrinology. 2025-03-01
160 citations
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Jan Biegus, Adriaan A Voors, Sean P Collins, Mikhail N Kosiborod, John R Teerlink
European Heart Journal. 2023-01-01
37 citations
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
Adriaan A Voors, Kevin Damman, John R Teerlink, Christiane E Angermann, Sean P Collins
European Journal of Heart Failure. 2022-10-01

Journal Articles

Empagliflozin Compared with Glimepiride in Metformin‐Treated Patients with Type 2 Diabetes: 208‐Week Data from a Masked Randomized Controlled Trial
Afshin Salsali, MD, Diabetes, Obesity and Metabolism